Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-04 @ 6:16 AM
Study NCT ID:
NCT06921759
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2025-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'C561806', 'term': 'lebrikizumab'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 206}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2025-04-21', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2025-11', 'completionDateStruct': {'date': '2026-09', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-11-03', 'studyFirstSubmitDate': '2025-04-04', 'studyFirstSubmitQcDate': '2025-04-04', 'lastUpdatePostDateStruct': {'date': '2025-11-04', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2025-04-10', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-07', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Percentage of Participants Achieving a Hand and Foot Investigator Global Assessment (HF-IGA) Score of 0 or 1 with ≥2-point Improvement from Baseline', 'timeFrame': 'Week 16', 'description': 'The HF-IGA is an assessment scale used to determine the severity of hand and foot atopic dermatitis (AD) and clinical response to treatment on a 5-point scale, 0 (clear) to 4 (severe). Higher scores indicate more disease severity.'}], 'secondaryOutcomes': [{'measure': 'Percentage of Participants with a HF-Peak Pruritus Numeric Rating Score (NRS) of ≥4 points at Baseline Who Achieve a ≥4-point Reduction (Improvement) from Baseline', 'timeFrame': 'Week 16', 'description': 'The HF-peak pruritus NRS scale is an assessment tool used daily by the participants to rate their worst hand and feet itch intensity on a scale ranging from 0 (no itch) to 10 (worst imaginable itch).'}, {'measure': 'Percentage of Participants Who Are "Satisfied" or "Very Satisfied" on Atopic Hand Dermatitis Clearance Satisfaction (AHDCS)', 'timeFrame': 'Week 16', 'description': "This single-item question assesses participants' satisfaction with hand clearance at the current time. The response options are reported as the percentage of participants who selected 1 of the following: Very Satisfied, Satisfied, Neither Satisfied nor Dissatisfied, Dissatisfied, or Very Dissatisfied."}, {'measure': 'Percent Change from Baseline in Hand and Foot Peak Pain NRS', 'timeFrame': 'Baseline, Week 16', 'description': 'The HF-peak pain NRS Scale is an assessment tool used daily by the participants to report the intensity of pain. Participants select the number between 0 and 10 that best fits their worst pain intensity over the past 24 hours (0 = no pain and 10 = the worst pain possible).'}, {'measure': 'Percentage of Participants with HF-Peak Pruritus NRS of ≥4 points at Baseline Who Achieve a ≥4-point Reduction (Improvement) from Baseline', 'timeFrame': 'Baseline, Week 4', 'description': 'The HF-peak pruritus NRS scale is an assessment tool used daily by the participants to rate their worst hand and feet itch intensity on a scale ranging from 0 (no itch) to 10 (worst imaginable itch).'}, {'measure': 'Percent Change from Baseline in Modified Total Lesion Symptom Scale (mTLSS) for Hand and Foot Lesions', 'timeFrame': 'Baseline, Week 16', 'description': 'The mTLSS is an investigator-reported scale that combines the evaluation of lesion severity of hand eczema (HE) (erythema, edema, desquamation, fissures, hyperkeratosis or lichenification, and vesicles) with the intensity of pruritus or pain to assess the severity of symptoms. This composite score assigns 0 (mild) to 3 (severe) to each component, giving a maximum disease severity of 21. A separate score is assigned for hands and feet.'}, {'measure': 'Percent Change from Baseline in Hand Eczema Severity Index (HECSI) Score for Participants with Hand Dermatitis', 'timeFrame': 'Baseline, Week 16', 'description': 'The HECSI scoring system incorporates both the extent and the intensity of the disease. The total sum called the HECSI score will be calculated, varying from 0 to a maximum severity score of 360 points.'}, {'measure': 'Percentage of Participants with Hand Dermatitis Achieving HECSI-50 Score', 'timeFrame': 'Week 16', 'description': 'The HECSI scoring system incorporates both the extent and the intensity of the disease. The total sum called the HECSI score will be calculated, varying from 0 to a maximum severity score of 360 points.'}, {'measure': 'Percentage of Participants with Hand Dermatitis Achieving HECSI-75 Score', 'timeFrame': 'Week 16', 'description': 'The HECSI scoring system incorporates both the extent and the intensity of the disease. The total sum called the HECSI score will be calculated, varying from 0 to a maximum severity score of 360 points.'}, {'measure': 'Percentage of Participants with Hand Dermatitis Achieving HECSI-90 Score', 'timeFrame': 'Week 16', 'description': 'The HECSI scoring system incorporates both the extent and the intensity of the disease. The total sum called the HECSI score will be calculated, varying from 0 to a maximum severity score of 360 points.'}, {'measure': 'Change from Baseline in Quality of Life in Hand Eczema Questionnaire (QOLHEQ) for Participants with Hand Dermatitis', 'timeFrame': 'Baseline, Week 16', 'description': 'The QOLHEQ consists of 30 items that can be summarized according to 4 domains of HRQoL: impairments over the last 7 days because of (1) symptoms, (2) emotions, (3) limitations in functioning, or (4) treatment and prevention. The total QOLHEQ score ranges between 0 and 117, with higher scores indicative of a poor HE-specific HRQoL.'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Atopic Hand and Foot Dermatitis']}, 'referencesModule': {'seeAlsoLinks': [{'url': 'http://trials.lilly.com/en-US/trial/591896', 'label': 'Related Info'}]}, 'descriptionModule': {'briefSummary': 'The main purpose of this study is to assess the efficacy of lebrikizumab versus placebo on skin lesions in adults and adolescent participants with atopic hand and foot dermatitis.\n\nThis study lasts up to 32 weeks, including a 6-week screening period, a 16-week treatment period, and a safety follow-up visit 12 weeks after the last dose.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'minimumAge': '12 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Have an unequivocal diagnosis of chronic atopic hand and/or foot dermatitis at least 1 year prior to screening, regardless of the extent and severity of concomitant atopic dermatitis (AD) on other areas of the body. AD must be present in at least 2 of the 4 mentioned anatomical areas: left hand, right hand, left foot, or right foot at screening and baseline.\n* Have a Hand Foot - Investigator Global Assessment (HF-IGA) score of 3 or 4 at the screening and baseline visits.\n* Have a baseline hand and foot peak pruritus (numeric rating scale) NRS score ≥4.\n* Have a documented history by the investigator of inadequate response to topical corticosteroids (TCS) in the treatment of atopic hand foot dermatitis (AHFD) within 6 months of screening, or use of TCS is medically inadvisable (due to intolerance to treatment, hypersensitivity reactions, significant skin atrophy of hand and feet, and systemic effects, as assessed by the investigator or by the treating physician of the participant).\n* For adolescent participants, body weight ≥40 kilograms (kg) at baseline.\n\nExclusion Criteria:\n\n* Have a positive patch test reaction to 1 or more allergens (a score of 1+ or above according to the International Contact Dermatitis Research Group grading scale) before baseline AND which are deemed to be clinically relevant in the view of the investigator as the current cause of the hand and foot dermatitis.\n* Have a documented diagnosis of allergic contact dermatitis (ACD) of hands and/or feet, and have a positive patch test reaction at screening, regardless of whether the history of current skin exposure to products containing this allergen (current relevance) is present.\n* Have a documented or strong clinical suspicion of the diagnosis of protein contact dermatitis of hands and/or feet. These are the participants with occupational or nonoccupational contact with proteins such as food, latex, and so on, who have positive prick test results and present with lesions of contact urticaria or dermatitis on hands and feet.\n* Have a documented exposure to irritants in the occupational or non-occupational (household/recreational) setting that is believed to be a predominant cause of the current hand and foot dermatitis as per the judgment of the investigator.\n* Presence of skin comorbidities on hand and/or foot that may interfere with study assessments, such as (but not limited to) palmoplantar psoriasis, palmoplantar keratoderma, impetiginized eczema, lichen planus, pityriasis rubra pilaris, herpes simplex, erythema multiforme, tinea, or scabies.\n* Have skin comorbidities that may interfere with study assessments\n* Treatment with topical medications within 2 weeks before the baseline visit (except for the use of the participant's own emollients).\n* Prior treatment with interleukin-13 (IL-13) inhibitors such as lebrikizumab or tralokinumab.\n* Have received any live attenuated vaccine within less than 4 weeks of the baseline visit or intend to receive a live attenuated vaccine during the study, or within 4 weeks after receiving the last dose of study intervention."}, 'identificationModule': {'nctId': 'NCT06921759', 'acronym': 'ADtouch', 'briefTitle': 'A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis', 'organization': {'class': 'INDUSTRY', 'fullName': 'Eli Lilly and Company'}, 'officialTitle': 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Lebrikizumab in Adult and Adolescent Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis', 'orgStudyIdInfo': {'id': '27349'}, 'secondaryIdInfos': [{'id': 'J2T-MC-KGCD', 'type': 'OTHER', 'domain': 'Eli Lilly and Company'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Lebrikizumab', 'description': 'Lebrikizumab administered subcutaneously (SC).', 'interventionNames': ['Drug: Lebrikizumab']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'Placebo Administered SC.', 'interventionNames': ['Drug: Placebo']}], 'interventions': [{'name': 'Lebrikizumab', 'type': 'DRUG', 'otherNames': ['LY3650150'], 'description': 'Administered SC', 'armGroupLabels': ['Lebrikizumab']}, {'name': 'Placebo', 'type': 'DRUG', 'description': 'Administered SC', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '85006', 'city': 'Phoenix', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '602-354-5770'}, {'name': 'Lindsay Ackerman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Medical Dermatology Specialists', 'geoPoint': {'lat': 33.44838, 'lon': -112.07404}}, {'zip': '92708', 'city': 'Fountain Valley', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '714-531-2966'}, {'name': 'Vivian Laquer', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'First OC Dermatology Research Inc', 'geoPoint': {'lat': 33.70918, 'lon': -117.95367}}, {'zip': '90045', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '310-337-7171'}, {'name': 'Howard Sofen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dermatology Research Associates', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '33024', 'city': 'Hollywood', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '954-400-1725'}, {'name': 'Jerome Obed', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Encore Medical Research', 'geoPoint': {'lat': 26.0112, 'lon': -80.14949}}, {'zip': '33134', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Kristin Haushalter', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Research Associates of South Florida - Miami - Southwest 8th Street', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '34470', 'city': 'Ocala', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '352-629-5800'}, {'name': 'Ashley Cauthen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Renstar Medical Research', 'geoPoint': {'lat': 29.1872, 'lon': -82.14009}}, {'zip': '60602', 'city': 'Chicago', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'George Lewitt', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'DeNova Research', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '46250', 'city': 'Indianapolis', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '317-516-5030'}, {'name': 'Scott Fretzin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dawes Fretzin Clinical Research Group, LLC', 'geoPoint': {'lat': 39.76838, 'lon': -86.15804}}, {'zip': '47150', 'city': 'New Albany', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '502-373-8133'}, {'name': 'Megan Landis', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Southern Indiana Clinical Trials', 'geoPoint': {'lat': 38.28562, 'lon': -85.82413}}, {'zip': '48084', 'city': 'Troy', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '248-590-0298'}, {'name': 'Ali Moiin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Revival Research Institute, LLC', 'geoPoint': {'lat': 42.60559, 'lon': -83.14993}}, {'zip': '64506', 'city': 'Saint Joseph', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '816-364-1515'}, {'name': 'MELODY STONE', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'MediSearch Clinical Trials', 'geoPoint': {'lat': 39.76861, 'lon': -94.84663}}, {'zip': '07030', 'city': 'Hoboken', 'state': 'New Jersey', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '551-278-8680'}, {'name': 'Adolfo Fernandez- Obregon', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Care Access - Hoboken', 'geoPoint': {'lat': 40.74399, 'lon': -74.03236}}, {'zip': '44512', 'city': 'Boardman', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '330-422-3234'}, {'name': 'Patrick Shannon', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Optima Research - Boardman', 'geoPoint': {'lat': 41.02423, 'lon': -80.66285}}, {'zip': '78213', 'city': 'San Antonio', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '210-614-5557'}, {'name': 'Mark Lee', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Progressive Clinical Research', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '78218', 'city': 'San Antonio', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '210-852-2779'}, {'name': 'John Browning', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Texas Dermatology and Laser Specialists', 'geoPoint': {'lat': 29.42412, 'lon': -98.49363}}, {'zip': '77479', 'city': 'Sugar Land', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Vandana Madkan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Complete Dermatology', 'geoPoint': {'lat': 29.61968, 'lon': -95.63495}}, {'zip': '1012', 'city': 'Buenos Aires', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '5411-3989-9011'}, {'name': 'Pablo Gonzalez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'CONEXA Investigacion Clinica S.A.', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1056ABH', 'city': 'Buenos Aires', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'name': 'Maria Greco', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Investigaciones Medicas Imoba Srl', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1061AAS', 'city': 'Buenos Aires', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '541148756767'}, {'name': 'Mariano Marini', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'CIPREC', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1425BEA', 'city': 'Buenos Aires', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '54114823-0919'}, {'name': 'Paula Luna', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Instituto de Neumonologia Y Dermatologia', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1425DKG', 'city': 'Buenos Aires', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '541148238755'}, {'name': 'Gabriel Magariños', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Psoriahue', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': 'C1426ABP', 'city': 'Buenos Aires', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '+54 1170781548'}, {'name': 'Maria Fernández', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fundación Respirar', 'geoPoint': {'lat': -34.61315, 'lon': -58.37723}}, {'zip': '5500', 'city': 'Mendoza', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '0054-2613961050'}, {'name': 'VIVIANA PARRA', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Parra Dermatología', 'geoPoint': {'lat': -32.88946, 'lon': -68.84582}}, {'zip': '2000', 'city': 'Rosario', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '+543412384171'}, {'name': 'Clara Bernardini', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fundacion Estudios Clinicos', 'geoPoint': {'lat': -32.94682, 'lon': -60.63932}}, {'zip': '2000', 'city': 'Rosario', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '3414252685'}, {'name': 'Yanina Pistelli', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'INECO Neurociencias Oroño', 'geoPoint': {'lat': -32.94682, 'lon': -60.63932}}, {'zip': 'S2000CVD', 'city': 'Rosario', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'role': 'CONTACT', 'phone': '0341 4472217'}, {'name': 'Marcela Cariñani', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Instituto de Investigaciones Clinicas Rosario', 'geoPoint': {'lat': -32.94682, 'lon': -60.63932}}, {'zip': '1663', 'city': 'San Miguel', 'status': 'RECRUITING', 'country': 'Argentina', 'contacts': [{'name': 'Adrian Schejtman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centro de Investigaciones San Miguel', 'geoPoint': {'lat': -34.54335, 'lon': -58.71229}}, {'zip': '4217', 'city': 'Benowa', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Michael Freeman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'The Skin Centre', 'geoPoint': {'lat': -28.0077, 'lon': 153.38583}}, {'zip': '3053', 'city': 'Carlton', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'PETER FOLEY', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Skin Health Institute Inc.', 'geoPoint': {'lat': -37.8, 'lon': 144.96667}}, {'zip': '4151', 'city': 'Coorparoo', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'role': 'CONTACT', 'phone': '07 3397 3200'}, {'name': 'Young Jin Kim', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cornerstone Dermatology', 'geoPoint': {'lat': -27.49325, 'lon': 153.05826}}, {'zip': '6160', 'city': 'Fremantle', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'role': 'CONTACT', 'phone': '0894304488'}, {'name': 'Kurt Gebauer', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Fremantle Dermatology', 'geoPoint': {'lat': -32.05632, 'lon': 115.74557}}, {'zip': '2217', 'city': 'Kogarah', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Esther Hong', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'St George Dermatology & Skin Cancer Centre', 'geoPoint': {'lat': -33.9681, 'lon': 151.13564}}, {'zip': '3132', 'city': 'Mitcham', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'John Su', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Institute for Skin, Health and Immunity', 'geoPoint': {'lat': -37.81667, 'lon': 145.2}}, {'zip': '2606', 'city': 'Phillip', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'name': 'Diana Rubel', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Paratus Clinical Research Woden', 'geoPoint': {'lat': -35.35035, 'lon': 149.09151}}, {'zip': '4102', 'city': 'Woolloongabba', 'status': 'RECRUITING', 'country': 'Australia', 'contacts': [{'role': 'CONTACT', 'phone': '001161730391300'}, {'name': 'Lynda Spelman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Veracity Clinical Research', 'geoPoint': {'lat': -27.48855, 'lon': 153.03655}}, {'zip': 'L4M 7G1', 'city': 'Barrie', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '7055036331'}, {'name': 'MARYAM SHAYESTEH ALAM', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'SimcoDerm Medical and Surgical Dermatology Center', 'geoPoint': {'lat': 44.40011, 'lon': -79.66634}}, {'zip': 'G7H 7Y8', 'city': 'Chicoutimi', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '418-602-6620'}, {'name': 'Dominique Desrosiers', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'INTERMED Groupe Sante', 'geoPoint': {'lat': 48.41963, 'lon': -71.06369}}, {'zip': 'V1W 4V5', 'city': 'Kelowna', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Dianne Burrows', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Interior Dermatology Centre - Probity - PPDS', 'geoPoint': {'lat': 49.88307, 'lon': -119.48568}}, {'zip': 'N6H 5L5', 'city': 'London', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '519-204-6868'}, {'name': 'Wei Jing Loo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'DermEffects', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'zip': 'H1Y 3L1', 'city': 'Montreal', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Catherine Tremblay', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centre de Recherche Saint-Louis', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'G1W 4R4', 'city': 'Québec', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '418-780-3501'}, {'name': 'Virginie Kelly', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Centre de Recherche Saint-Louis', 'geoPoint': {'lat': 46.81228, 'lon': -71.21454}}, {'zip': 'T4P 1K4', 'city': 'Red Deer', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'name': 'Isaiah Day', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'CaRe Clinic', 'geoPoint': {'lat': 52.26682, 'lon': -113.802}}, {'zip': 'S4V 1R9', 'city': 'Regina', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '306-570-8177'}, {'name': 'Rachel Asiniwasis', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Private Practice - Dr. Rachel Asiniwasis', 'geoPoint': {'lat': 50.45008, 'lon': -104.6178}}, {'zip': 'M4E 1R7', 'city': 'Toronto', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '416-698-5521'}, {'name': 'Geeta Yadav', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'FACET Dermatology', 'geoPoint': {'lat': 43.70643, 'lon': -79.39864}}, {'zip': 'R3M 3Z4', 'city': 'Winnipeg', 'status': 'RECRUITING', 'country': 'Canada', 'contacts': [{'role': 'CONTACT', 'phone': '204-943-4922'}, {'name': 'Marni Wiseman', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Wiseman Dermatology Research Inc.', 'geoPoint': {'lat': 49.8844, 'lon': -97.14704}}, {'zip': '211-0063', 'city': 'Kawasaki-shi', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Aisaku Yamamoto', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kosugi Dermatology Clinic'}, {'zip': '136-0074', 'city': 'Kōtoku', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Ryuji Maruyama', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Maruyama Dermatology Clinic', 'geoPoint': {'lat': 42.50417, 'lon': 143.14297}}, {'zip': '602-8566', 'city': 'Kyoto', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Koji Masuda', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University Hospital,Kyoto Prefectural University of Medicine', 'geoPoint': {'lat': 35.02107, 'lon': 135.75385}}, {'zip': '143-0023', 'city': 'Ōta-ku', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Yumiko Kudo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Tanpopo Skin Clinic', 'geoPoint': {'lat': 35.56126, 'lon': 139.71605}}, {'zip': '330-0064', 'city': 'Saitama', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'HISAE MUKAIKUBO', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Pansy Skin Clinic', 'geoPoint': {'lat': 35.90807, 'lon': 139.65657}}, {'zip': '593-8324', 'city': 'Sakai', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Akihiro Kume', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dermatology and Ophthalmology Kume Clinic', 'geoPoint': {'lat': 34.58216, 'lon': 135.46653}}, {'zip': '160-0023', 'city': 'Shinjuku-ku', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Yukari Okubo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Tokyo Medical University Hospital'}, {'zip': '190-0023', 'city': 'Tachikawa', 'status': 'RECRUITING', 'country': 'Japan', 'contacts': [{'role': 'CONTACT', 'phone': '81120023812'}, {'name': 'Hideki Ito', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Tachikawa Dermatology Clinic', 'geoPoint': {'lat': 35.7091, 'lon': 139.41891}}, {'zip': '31203', 'city': 'Chihuahua City', 'status': 'RECRUITING', 'country': 'Mexico', 'contacts': [{'name': 'JACQUELINE AGUIRRE SOTELO', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Scientia Investigacion Clinica S.C.', 'geoPoint': {'lat': 28.63528, 'lon': -106.08889}}, {'zip': '06100', 'city': 'Cuauhtémoc, Ciudad de México', 'status': 'RECRUITING', 'country': 'Mexico', 'contacts': [{'role': 'CONTACT', 'phone': '525585373247'}, {'name': 'Monica de la Torre', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cryptex Investigación Clínica S.A. de C.V.'}, {'zip': '44638', 'city': 'Guadalajara', 'status': 'NOT_YET_RECRUITING', 'country': 'Mexico', 'contacts': [{'name': 'Delfina Villanueva Quintero', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Grupo Clínico CATEI S.C.', 'geoPoint': {'lat': 20.67738, 'lon': -103.34749}}, {'zip': '03100', 'city': 'Mexico City', 'status': 'NOT_YET_RECRUITING', 'country': 'Mexico', 'contacts': [{'role': 'CONTACT', 'phone': '5518669106'}, {'name': 'Zamira Barragan-Estudillo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'RM Pharma Specialists', 'geoPoint': {'lat': 19.42847, 'lon': -99.12766}}, {'zip': '97070', 'city': 'Mérida', 'status': 'RECRUITING', 'country': 'Mexico', 'contacts': [{'name': 'Claudia Calderon Rocher', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kohler & Milstein Research S.A. De C.V.', 'geoPoint': {'lat': 20.967, 'lon': -89.62318}}, {'zip': '64718', 'city': 'Monterrey', 'status': 'RECRUITING', 'country': 'Mexico', 'contacts': [{'name': 'Jorge Garza Gomez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Eukarya Pharmasite S.C.', 'geoPoint': {'lat': 25.68435, 'lon': -100.31721}}, {'zip': '91900', 'city': 'Veracruz', 'status': 'RECRUITING', 'country': 'Mexico', 'contacts': [{'role': 'CONTACT', 'phone': '2299314102'}, {'name': 'Claudia Bernabe del Rio', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Arké SMO S.A de C.V', 'geoPoint': {'lat': 19.18095, 'lon': -96.1429}}, {'zip': '45190', 'city': 'Zapopan', 'status': 'NOT_YET_RECRUITING', 'country': 'Mexico', 'contacts': [{'name': 'RAQUEL ROJAS CASTAÑEDA', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Instituto Dermatologico de Jalisco', 'geoPoint': {'lat': 20.72111, 'lon': -103.38742}}, {'zip': '15355', 'city': 'Ansan-si', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'role': 'CONTACT', 'phone': '01082795183'}, {'name': 'Sang Wook Son', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Korea University Ansan Hospital', 'geoPoint': {'lat': 37.32361, 'lon': 126.82194}}, {'zip': '21431', 'city': 'Bupyeong-gu', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'role': 'CONTACT', 'phone': '0322805103'}, {'name': 'Sang-Hyun Cho', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "The Catholic University of Korea, Incheon St. Mary's Hospital"}, {'zip': '50612', 'city': 'Busan', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Hyun Chang Ko', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Pusan National University Yangsan Hospital', 'geoPoint': {'lat': 35.10168, 'lon': 129.03004}}, {'zip': '61453', 'city': 'Gwangju', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Chan-Ho Na', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Chosun University Hospital', 'geoPoint': {'lat': 35.15472, 'lon': 126.91556}}, {'zip': '41944', 'city': 'Junggu', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Yong Hyun Jang', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kyungpook National University Hospital', 'geoPoint': {'lat': 37.69175, 'lon': 126.60024}}, {'zip': '03080', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Dong Hun Lee', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Seoul National University Hospital', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '03722', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Chang Ook Park', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Severance Hospital, Yonsei University Health System', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '05030', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Yang won Lee', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Konkuk University Medical Center', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '05278', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Bark Lynn Lew', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Kyung Hee University Hospital at Gangdong', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '05505', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'name': 'Chong Hyun Won', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Asan Medical Center', 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '06591', 'city': 'Seoul', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'role': 'CONTACT', 'phone': '+82 10 8969 1983'}, {'name': 'YOUNG MIN PARK', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': "The Catholic Univ. of Korea Seoul St. Mary's Hospital", 'geoPoint': {'lat': 37.566, 'lon': 126.9784}}, {'zip': '16499', 'city': 'Suwon', 'status': 'RECRUITING', 'country': 'South Korea', 'contacts': [{'role': 'CONTACT', 'phone': '82312195152'}, {'name': 'Dong-Ho Nahm', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ajou University Hospital', 'geoPoint': {'lat': 37.29111, 'lon': 127.00889}}, {'zip': '83301', 'city': 'Kaohsiung Niao Sung Dist', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '+8867317123-2299'}, {'name': 'Ji-Chen Ho', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Chang Gung Memorial Hospital at Kaohsiung'}, {'zip': '236', 'city': 'New Taipei City', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '886-975-366-337'}, {'name': 'Chin-Yi Yang', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'New Taipei Municipal TuCheng Hospital', 'geoPoint': {'lat': 25.06199, 'lon': 121.45703}}, {'zip': '704', 'city': 'Tainan', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '+886-6-2353535-5418'}, {'name': 'Chao-Chun Yang', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'National Cheng Kung University Hospital', 'geoPoint': {'lat': 22.99083, 'lon': 120.21333}}, {'zip': '10002', 'city': 'Taipei', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '+886223562141'}, {'name': 'Chia-Yu Chu', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'National Taiwan University Hospital', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '11217', 'city': 'Taipei', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '02-2875-7339'}, {'name': 'Chih-Chiang Chen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Taipei Veterans General Hospital', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '114', 'city': 'Taipei', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '886-8792-3311'}, {'name': 'Yi-Hsien Chen', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Tri-Service General Hospital', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}, {'zip': '333', 'city': 'Taoyuan District', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'name': 'Ya-Ching Chang', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Chang Gung Medical Foundation-Linkou Branch', 'geoPoint': {'lat': 24.9896, 'lon': 121.3187}}, {'zip': '302', 'city': 'Zhubei', 'status': 'RECRUITING', 'country': 'Taiwan', 'contacts': [{'role': 'CONTACT', 'phone': '88635326151ext.2957'}, {'name': 'HSIEN-YI CHIU', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'National Taiwan University Hospital - Hsinchu branch', 'geoPoint': {'lat': 24.83833, 'lon': 121.00778}}], 'centralContacts': [{'name': 'Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or', 'role': 'CONTACT', 'email': 'LillyTrials@Lilly.com', 'phone': '1-317-615-4559'}, {'name': 'Physicians interested in becoming principal investigators please contact', 'role': 'CONTACT', 'email': 'clinical_inquiry_hub@lilly.com'}], 'overallOfficials': [{'name': 'Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Eli Lilly and Company'}]}, 'ipdSharingStatementModule': {'url': 'http://vivli.org/', 'infoTypes': ['STUDY_PROTOCOL', 'SAP', 'CSR'], 'timeFrame': 'Data are available 6 months after the primary publication and approval of the indication studied in the US and EU, whichever is later. Data will be indefinitely available for requesting.', 'ipdSharing': 'YES', 'description': 'Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.', 'accessCriteria': 'A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Eli Lilly and Company', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}